NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 16
Auteur Titel [ Jaar(Asc)]
Filters: Auteur is Schellekens, Arnt F A  [Alle filters opschonen]
2019
Arends RM, Nelwan EJ, Soediro R, van Crevel R, Alisjahbana B, Pohan HT, A von Borries KL, Schene AH, Van der Ven AJAM, Schellekens AFA.  2019.  Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study. PLoS One. 14(2):e0207970.
Groefsema MM, Engels RCME, Voon V, Schellekens AFA, Luijten M, Sescousse G.  2019.  Brain responses to anticipating and receiving beer: Comparing light, at-risk, and dependent alcohol users. Addict Biol. :e12766.
Coenen NCB, Dijkstra BAG, Batalla A, Schellekens AFA.  2019.  Detoxification of a Patient With Comorbid Dependence on Phenibut and Benzodiazepines by Tapering With Baclofen: Case Report. J Clin Psychopharmacol. 39(5):511-514.
van den Brink W, Schellekens AFA.  2019.  Hoofdstuk 14 Farmacologische interventies. Handboek Verslaving.
Belgers M, Schellekens AFA.  2019.  Hoofdstuk 23 Somatische comorbiditeit bij verslaving. Handboek Verslaving.
Batalla A, Schellekens AFA.  2019.  Hoofdstuk 26 Verslaving en internaliserende problematiek. Handboek Verslaving.
Vink J, Schellekens AFA.  2019.  Hoofdstuk 7 Genetica van verslaving. Handboek Verslaving.
van Rijswijk SM, van Beek MHCT, Schoof GM, Schene AH, Steegers M, Schellekens AFA.  2019.  Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review. Gen Hosp Psychiatry. 59:37-50.
Schellekens AFA, Vanderschuren L.  2019.  Neurobiologie van verslaving. Handboek Verslaving.
Van de Wijer L, Garcia LP, Hanswijk SI, Rando J, Middelman A, Heine RTer, de Mast Q, Martens GJM, Van der Ven AJAM, Kolk SM et al..  2019.  Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model. Transl Psychiatry. 9(1):84.
Van de Wijer L, Mchaile DN, de Mast Q, Mmbaga BT, Rommelse NNJ, Duinmaijer A, Van der Ven AJAM, Schellekens AFA, Kinabo GD.  2019.  Neuropsychiatric symptoms in Tanzanian HIV-infected children receiving long-term efavirenz treatment: a multicentre, cross-sectional, observational study. Lancet HIV. 6(4):e250-e258.
Beurmanjer H, Asperslag EM, Oliemeulen L, Goudriaan AE, De Jong CAJ, Schellekens AFA, Dijkstra BAG.  2019.  A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.. Eur Addict Res. 25(5):248-255.
van Esch AMJ, Fest A, Hoffland BS, Janzing JGE, Steens SCA, Esselink RAJ, Schellekens AFA.  2019.  Toxic Leukoencephalopathy Presenting as Lethal Catatonia. J Addict Med. 13(3):241-244.
2018
Beurmanjer H, Kamal RM, de Jong CAJ, Dijkstra BAG, Schellekens AFA.  2018.  Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.. CNS Drugs. 32(5):437-442.
Knuijver T, Belgers M, Markus W, Verkes R-J, van Oosteren T, Schellekens AFA.  2018.  Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. J Clin Psychopharmacol. 38(6):646-648.
2017
van Noorden MS, Kamal R, Beurmanjer H, Dijkstra BAG, Schellekens AFA.  2017.  [Reaction on 'Hypernatremia caused by treatment with GHB obtained via a doctor's prescription'].. Tijdschr Psychiatr. 59(3):195-196.